U.S. Embassy Uganda Announces Introduction of Lenacapavir, a Groundbreaking HIV Prevention Medicine, Demonstrating American Excellence in Science and American Leadership in HIV Prevention
Press Release | U.S. Embassy Uganda Announces Introduction of Lenacapavir, a Groundbreaking HIV Prevention Medicine
Kampala, September 30, 2025 –
The U.S. Department of State introduced a life-saving growth to deliver U.S.-based Gilead Sciences’ breakthrough drug lenacapavir to market in Uganda, one of simply ten high-burden HIV nations the place the drug will likely be distributed via the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). The U.S. initiative – which can promote international scale in manufacturing and distribution of the medicine and catalyze additional international funding has the potential to avoid wasting a whole bunch of 1000’s of lives.
The United States, in collaboration with the Ugandan Ministry of Health, will introduce lenacapavir in 2026. Taken solely twice a yr, lenacapavir provides a extremely efficient and handy HIV prevention possibility for people at excessive danger of HIV acquisition. Clinical trials present greater than 99% of folks on lenacapavir remained HIV unfavourable.
This progressive medicine represents a important development in Uganda’s combat towards HIV/AIDS, notably for pregnant and breastfeeding moms. The U.S. authorities and the Global Fund, of which the U.S. authorities is the most important donor, are co-funding this superior market dedication to buy lenacapavir for as much as 2 million people by 2028 in nations with the most important HIV/AIDS epidemics. Gilead has agreed to offer the drug at price. In addition, Gilead has agreed to offer their mental property to generic producers who can produce the drug at scale and assist deliver down the worth in order that future purchases could be sustained by native governments.
Ambassador William W. Popp emphasised lenacapavir’s transformative potential, stating, “This medicine is an excellent example of how American leadership drives innovation to save lives. Collaboration between an American company and researchers right here in Uganda led to a medical breakthrough to reduce new HIV infections in the communities that need it most. This exciting development will accelerate our progress toward ending HIV as a public health threat, building a healthier future for America, Uganda, and the world.”
The United States will work carefully with the Government of Uganda to develop a rollout plan for this life-saving medicine.
For extra data, please contact KampalaPress@state.gov.
The publish U.S. Embassy Uganda Announces Introduction of Lenacapavir, a Groundbreaking HIV Prevention Medicine appeared first on U.S. Embassy in Uganda.
